Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split
WAYNE, Pa. and ROCKVILLE, Md., Dec. 07, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:AVTX) encourages its stockholders to participate actively in the upcoming adjourned annual meeting of stockholders, initially convened on December 5, 2023, and scheduled to reconvene on Wednesday, December 20, 2023. The initial meeting lacked a quorum, with insufficient votes to approve the reverse stock split proposal.
Related news for (AVTX)
- Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
- Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
- Notable 28 March 2024 Headlines
- Avalo Acquires AlmataBio and Agrees to Private Placement Financing of up to $185 Million
- Avalo Therapeutics Announces 1-for-240 Reverse Stock Split